Immediate Impact

5 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
2 intermediate papers

Works of Amy E. Veroff being referenced

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
2002
A New Assessment Tool for Neuropsychopharmacologic Research: The Computerized Neuropsychological Test Battery
1991

Author Peers

Author Last Decade Papers Cites
Amy E. Veroff 223 179 132 208 22 614
Haythum O. Tayeb 112 63 165 131 38 528
Anh Duong 257 237 308 159 12 641
V Rajmohan 179 138 154 86 22 664
Sarah Chau 114 82 283 133 18 719
Brendon Binneman 228 89 138 120 17 580
L. S. Schneider 174 41 279 178 9 652
Tsuneyoshi Ota 186 115 241 197 25 678
Martin Farlow 181 64 173 294 10 550
W. James Deardorff 122 46 158 188 28 627
Timothy Hsu 229 84 197 164 20 640

All Works

Loading papers...

Rankless by CCL
2026